section name header

Y-Site Injection Compatibility (1:1 Mixture)

Ceftazidime

(Mfr: GSK)(Conc: 120 mg/mLk)

C

Dopamine HCl

(Conc: 0.4 mg/mL)

Remarks:

Physically compatible with less than 10% ceftazidime loss. Dopamine not tested

Ref:

2513